| [1] |
XIE Mengsheng, ZHAO Yang, CHEN Feng.
Statistical analysis of active extension trial
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1007-1013.
|
| [2] |
WANG Zeng, YUAN Mei-qin, YANG Guo-nong, DING Hai-ying.
Clinical research progress of ACEI/ARB used in tumor treatment
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(2): 230-234.
|
| [3] |
HE Yan, WANG Liang-you.
Inhibitor of thrombin, bivalirudin
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(3): 339-343.
|
| [4] |
WEN Shi-mei, CHEN Yun-fei, LIU Hua.
SAS programming for sample size and power calculation of measurement data in non-inferior trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(1): 51-54.
|
| [5] |
XIE Hai-tang, SUN Hua, LI Juan, TONG Jiu-cui, JIANG Si-yan, LI Hai-gang, PAN Hang-shan, JIA Yuan-wei, SUN Rui-yuan.
Application of covariance analysis in phase Ⅱ clinical trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(11): 1240-1244.
|
| [6] |
XUE Jun, ZHOU Jian-dong, XIONG Ning-ning.
Commonly used SAS macro programs in blind data review of clinical trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(5): 535-540.
|
| [7] |
HU Si-yuan, MA Rong, LIU Xiao-fan, XIANG Xi-xiong, DING Ying, HUANG Wen-yu, HUANG Zhi-jun, XIAO Fei.
Phase Ⅲ clinical trial of Xiaoeryiniao Granule on children with enuresis of kidney-qi deficiency in comparing with meclofenoxate hydrochlorid capsules
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(1): 107-111.
|
| [8] |
LI Tao, GUO Lan.
Issues of clinical trails on traditional Chinese new drugs for diabetic poly-neuropathy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(12): 1401-1404.
|
| [9] |
LI Tao.
Some problems on clinical trails evalution of herbs medicine for insomnia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(4): 375-378.
|
| [10] |
YU Li-li, XUE Fu-bo, LI Chan-juan, WANG Su-zhen, XU Li, WANG Ling, XIA Jie-lai.
A SAS macro for analyzing measurement data in clinical trial of new drug
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(1): 111-115.
|
| [11] |
ZOU Jian-dong, XIONG Ning-ning, BO Qing-yan, JIANG Meng, LIU Fang.
Designing of SAS macro programs of fourfold table for report forms of statistical results
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(3): 357-360.
|
| [12] |
HUANG Yu-hong, WANG Bao-he, ZOU Shu-xuan, SUN Zeng-tao, SHANG Hong-cai, ZHANG Bo-li.
Risk management in clinical trails
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(11): 1215-1218.
|
| [13] |
YANG Juan, ZHENG Qing-shan.
Statistical methods of Meta-analysis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(11): 1225-1235.
|
| [14] |
YANG Juan, ZHENG Qing-shan.
Statistical methods of Meta-analysis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(11): 1309-1314.
|
| [15] |
HUANG Yu-hong, WANG Bao-he, ZOU Shu-xuan, SUN Zeng-tao, SHANG Hong-cai, ZHANG Bo-li.
Risk management in clinical trails
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(11): 1318-1320.
|
